<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35042241</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>20</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>15</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1460-2156</ISSN><JournalIssue CitedMedium="Internet"><Volume>145</Volume><Issue>2</Issue><PubDate><Year>2022</Year><Month>Apr</Month><Day>18</Day></PubDate></JournalIssue><Title>Brain : a journal of neurology</Title><ISOAbbreviation>Brain</ISOAbbreviation></Journal><ArticleTitle>Astrocytes display cell autonomous and diverse early reactive states in familial amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>481</StartPage><EndPage>489</EndPage><MedlinePgn>481-489</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/brain/awab328</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis is a rapidly progressive and fatal disease. Although astrocytes are increasingly recognized contributors to the underlying pathogenesis, the cellular autonomy and uniformity of astrocyte reactive transformation in different genetic forms of amyotrophic lateral sclerosis remain unresolved. Here we systematically examine these issues by using highly enriched and human induced pluripotent stem cell-derived astrocytes from patients with VCP and SOD1 mutations. We show that VCP mutant astrocytes undergo cell-autonomous reactive transformation characterized by increased expression of complement component 3 (C3) in addition to several characteristic gene expression changes. We then demonstrate that isochronic SOD1 mutant astrocytes also undergo a cell-autonomous reactive transformation, but that this is molecularly distinct from VCP mutant astrocytes. This is shown through transcriptome-wide analyses, identifying divergent gene expression profiles and activation of different key transcription factors in SOD1 and VCP mutant human induced pluripotent stem cell-derived astrocytes. Finally, we show functional differences in the basal cytokine secretome between VCP and SOD1 mutant human induced pluripotent stem cell-derived astrocytes. Our data therefore reveal that reactive transformation can occur cell autonomously in human amyotrophic lateral sclerosis astrocytes and with a striking degree of early molecular and functional heterogeneity when comparing different disease-causing mutations. These insights may be important when considering astrocyte reactivity as a putative therapeutic target in familial amyotrophic lateral sclerosis.</AbstractText><CopyrightInformation>&#xa9; The Author(s) (2022). Published by Oxford University Press on behalf of the Guarantors of Brain.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Taha</LastName><ForeName>Doaa M</ForeName><Initials>DM</Initials><AffiliationInfo><Affiliation>Department of Neuromuscular Diseases, Queen Square Institute of Neurology, University College London, London WC1N 3BG, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Francis Crick Institute, London NW1 1AT, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Zoology Department, Faculty of Science, Alexandria University, Alexandria 21511, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Clarke</LastName><ForeName>Benjamin E</ForeName><Initials>BE</Initials><AffiliationInfo><Affiliation>Department of Neuromuscular Diseases, Queen Square Institute of Neurology, University College London, London WC1N 3BG, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Francis Crick Institute, London NW1 1AT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hall</LastName><ForeName>Claire E</ForeName><Initials>CE</Initials><AffiliationInfo><Affiliation>Department of Neuromuscular Diseases, Queen Square Institute of Neurology, University College London, London WC1N 3BG, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Francis Crick Institute, London NW1 1AT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tyzack</LastName><ForeName>Giulia E</ForeName><Initials>GE</Initials><AffiliationInfo><Affiliation>Department of Neuromuscular Diseases, Queen Square Institute of Neurology, University College London, London WC1N 3BG, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Francis Crick Institute, London NW1 1AT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ziff</LastName><ForeName>Oliver J</ForeName><Initials>OJ</Initials><AffiliationInfo><Affiliation>Department of Neuromuscular Diseases, Queen Square Institute of Neurology, University College London, London WC1N 3BG, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Francis Crick Institute, London NW1 1AT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Greensmith</LastName><ForeName>Linda</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Neuromuscular Diseases, Queen Square Institute of Neurology, University College London, London WC1N 3BG, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kalmar</LastName><ForeName>Bernadett</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0003-3747-4843</Identifier><AffiliationInfo><Affiliation>Department of Neuromuscular Diseases, Queen Square Institute of Neurology, University College London, London WC1N 3BG, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahmed</LastName><ForeName>Mhoriam</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neuromuscular Diseases, Queen Square Institute of Neurology, University College London, London WC1N 3BG, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alam</LastName><ForeName>Aftab</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-8089-6721</Identifier><AffiliationInfo><Affiliation>Division of Neurosurgery and Wolfson Brain Imaging Centre, Department of Clinical Neurosciences, University of Cambridge, Cambridge CB2 0QQ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thelin</LastName><ForeName>Eric P</ForeName><Initials>EP</Initials><Identifier Source="ORCID">0000-0002-2338-4364</Identifier><AffiliationInfo><Affiliation>Division of Neurosurgery and Wolfson Brain Imaging Centre, Department of Clinical Neurosciences, University of Cambridge, Cambridge CB2 0QQ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garcia</LastName><ForeName>Nuria Marco</ForeName><Initials>NM</Initials><AffiliationInfo><Affiliation>Division of Neurosurgery and Wolfson Brain Imaging Centre, Department of Clinical Neurosciences, University of Cambridge, Cambridge CB2 0QQ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Helmy</LastName><ForeName>Adel</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Neurosurgery and Wolfson Brain Imaging Centre, Department of Clinical Neurosciences, University of Cambridge, Cambridge CB2 0QQ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sibley</LastName><ForeName>Christopher R</ForeName><Initials>CR</Initials><AffiliationInfo><Affiliation>Institute of Quantitative Biology, Biochemistry and Biotechnology, School of Biological Sciences, University of Edinburgh, Edinburgh EH8 9JZ, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Simons Initiative for the Developing Brain, University of Edinburgh, Hugh Robson Building, George Square, Edinburgh EH8 9XD, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Discovery Brain Sciences, University of Edinburgh, Hugh Robson Building, George Square, Edinburgh EH8 9XD, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Euan MacDonald Centre for MND Research, University of Edinburgh, Edinburgh, EH16 4SB, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patani</LastName><ForeName>Rickie</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-3825-7675</Identifier><AffiliationInfo><Affiliation>Department of Neuromuscular Diseases, Queen Square Institute of Neurology, University College London, London WC1N 3BG, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Francis Crick Institute, London NW1 1AT, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>G0802251</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/M02492X/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/S006591/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Brain</MedlineTA><NlmUniqueID>0372537</NlmUniqueID><ISSNLinking>0006-8950</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D013482">Superoxide Dismutase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C531617">Amyotrophic lateral sclerosis 1</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001253" MajorTopicYN="N">Astrocytes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057026" MajorTopicYN="Y">Induced Pluripotent Stem Cells</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013482" MajorTopicYN="N">Superoxide Dismutase</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis (ALS)</Keyword><Keyword MajorTopicYN="N">astrocytes</Keyword><Keyword MajorTopicYN="N">cell autonomous</Keyword><Keyword MajorTopicYN="N">diversity</Keyword><Keyword MajorTopicYN="N">reactive transformation</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>8</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>7</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>8</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>1</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>1</Month><Day>18</Day><Hour>20</Hour><Minute>30</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35042241</ArticleId><ArticleId IdType="pmc">PMC9014746</ArticleId><ArticleId IdType="doi">10.1093/brain/awab328</ArticleId><ArticleId IdType="pii">6510848</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Johnson JO, Mandrioli J, Benatar M, et al. ; ITALSGEN Consortium . Exome sequencing reveals VCP mutations as a cause of familial ALS. Neuron. 2010;68(5):857&#x2013;864.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3032425</ArticleId><ArticleId IdType="pubmed">21145000</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer H, Weihl CC.. The VCP/p97 system at a glance: Connecting cellular function to disease pathogenesis. J Cell Sci. 2014;127(Pt 18):3877&#x2013;3883.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4163641</ArticleId><ArticleId IdType="pubmed">25146396</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M, Sampathu DM, Kwong LK, et al. . Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314(5796):130&#x2013;133.</Citation><ArticleIdList><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Tziortzouda P, Van Den Bosch L, Hirth F.. Reply to &#x201c;TDP43 aggregates: The &#x2018;Schr&#xf6;dinger&#x2019;s cat&#x201d; in amyotrophic lateral sclerosis&#x2019;. Nat Rev Neurosci. 2021;22(8):515&#x2013;511.</Citation><ArticleIdList><ArticleId IdType="pubmed">34103711</ArticleId></ArticleIdList></Reference><Reference><Citation>Han RT, Kim RD, Molofsky AV, Liddelow SA.. Astrocyte-immune cell interactions in physiology and pathology. Immunity. 2021;54(2):211&#x2013;224.</Citation><ArticleIdList><ArticleId IdType="pubmed">33567261</ArticleId></ArticleIdList></Reference><Reference><Citation>Liddelow SA, Guttenplan KA, Clarke LE, et al. . Neurotoxic reactive astrocytes are induced by activated microglia. Nature. 2017;541(7638):481&#x2013;487.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5404890</ArticleId><ArticleId IdType="pubmed">28099414</ArticleId></ArticleIdList></Reference><Reference><Citation>Barbar L, Jain T, Zimmer M, et al. . CD49f is a novel marker of functional and reactive human iPSC-derived astrocytes. Neuron. 2020;107(3):436&#x2013;453.e12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8274549</ArticleId><ArticleId IdType="pubmed">32485136</ArticleId></ArticleIdList></Reference><Reference><Citation>Zamanian JL, Xu L, Foo LC, et al. . Genomic analysis of reactive astrogliosis. J Neurosci. 2012;32(18):6391&#x2013;6410.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3480225</ArticleId><ArticleId IdType="pubmed">22553043</ArticleId></ArticleIdList></Reference><Reference><Citation>Tyzack GE, Hall CE, Sibley CR, et al. . A neuroprotective astrocyte state is induced by neuronal signal EphB1 but fails in ALS models. Nat Commun. 2017;8(1):1164.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5660125</ArticleId><ArticleId IdType="pubmed">29079839</ArticleId></ArticleIdList></Reference><Reference><Citation>Roybon L, Lamas NJ, Garcia-Diaz A, et al. . Human stem cell-derived spinal cord astrocytes with defined mature or reactive phenotypes. Cell Rep. 2013;4(5):1035&#x2013;1048.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4229657</ArticleId><ArticleId IdType="pubmed">23994478</ArticleId></ArticleIdList></Reference><Reference><Citation>Serio A, Patani R.. Concise review: The cellular conspiracy of amyotrophic lateral sclerosis. Stem Cells. 2018;36(3):293&#x2013;303.</Citation><ArticleIdList><ArticleId IdType="pubmed">29235200</ArticleId></ArticleIdList></Reference><Reference><Citation>Hall CE, Yao Z, Choi M, et al. . Progressive motor neuron pathology and the role of astrocytes in a human stem cell model of VCP-related ALS. Cell Rep. 2017;19(9):1739&#x2013;1749.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5464993</ArticleId><ArticleId IdType="pubmed">28564594</ArticleId></ArticleIdList></Reference><Reference><Citation>Cahoy JD, Emery B, Kaushal A, et al. . A transcriptome database for astrocytes, neurons, and oligodendrocytes: A new resource for understanding brain development and function. J Neurosci. 2008;28(1):264&#x2013;278.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6671143</ArticleId><ArticleId IdType="pubmed">18171944</ArticleId></ArticleIdList></Reference><Reference><Citation>Efremova L, Chovancova P, Adam M, Gutbier S, Schildknecht S, Leist M.. Switching from astrocytic neuroprotection to neurodegeneration by cytokine stimulation. Arch Toxicol. 2017;91(1):231&#x2013;246.</Citation><ArticleIdList><ArticleId IdType="pubmed">27052459</ArticleId></ArticleIdList></Reference><Reference><Citation>Birger A, Ben-Dor I, Ottolenghi M, et al. . Human iPSC-derived astrocytes from ALS patients with mutated C9ORF72 show increased oxidative stress and neurotoxicity. EBioMedicine. 2019;50:274&#x2013;289.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6921360</ArticleId><ArticleId IdType="pubmed">31787569</ArticleId></ArticleIdList></Reference><Reference><Citation>Guttenplan KA, Weigel MK, Adler DI, et al. . Knockout of reactive astrocyte activating factors slows disease progression in an ALS mouse model. Nat Commun. 2020;11(1):3753.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7385161</ArticleId><ArticleId IdType="pubmed">32719333</ArticleId></ArticleIdList></Reference><Reference><Citation>Alvarez MJ, Shen Y, Giorgi FM, et al. . Functional characterization of somatic mutations in cancer using network-based inference of protein activity. Nat Genet. 2016;48(8):838&#x2013;847.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5040167</ArticleId><ArticleId IdType="pubmed">27322546</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Alonso L, Holland CH, Ibrahim MM, Turei D, Saez-Rodriguez J.. Benchmark and integration of resources for the estimation of human transcription factor activities. Genome Res. 2019;29(8):1363&#x2013;1375.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6673718</ArticleId><ArticleId IdType="pubmed">31340985</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu D, Lim E, Vaillant F, Asselin-Labat M-L, Visvader JE, Smyth GK.. ROAST: Rotation gene set tests for complex microarray experiments. Bioinformatics. 2010;26(17):2176&#x2013;2182.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2922896</ArticleId><ArticleId IdType="pubmed">20610611</ArticleId></ArticleIdList></Reference><Reference><Citation>Han H, Cho J-W, Lee S, et al. . TRRUST v2: An expanded reference database of human and mouse transcriptional regulatory interactions. Nucleic Acids Res. 2018;46(D1):D380&#x2013;D386.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5753191</ArticleId><ArticleId IdType="pubmed">29087512</ArticleId></ArticleIdList></Reference><Reference><Citation>Diaz-Castro B, Gangwani MR, Yu X, Coppola G, Khakh BS.. Astrocyte molecular signatures in Huntington&#x2019;s disease. Sci Transl Med. 2019;11(514):eaaw8546.</Citation><ArticleIdList><ArticleId IdType="pubmed">31619545</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Sloan SA, Clarke LE, et al. . Purification and characterization of progenitor and mature human astrocytes reveals transcriptional and functional differences with mouse. Neuron. 2016;89(1):37&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4707064</ArticleId><ArticleId IdType="pubmed">26687838</ArticleId></ArticleIdList></Reference><Reference><Citation>Serio A, Bilican B, Barmada SJ, et al. . Astrocyte pathology and the absence of non-cell autonomy in an induced pluripotent stem cell model of TDP-43 proteinopathy. Proc Natl Acad Sci U S A. 2013;110(12):4697&#x2013;4702.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3607024</ArticleId><ArticleId IdType="pubmed">23401527</ArticleId></ArticleIdList></Reference><Reference><Citation>Stevens B, Allen NJ, Vazquez LE, et al. . The classical complement cascade mediates CNS synapse elimination. Cell. 2007;131(6):1164&#x2013;1178.</Citation><ArticleIdList><ArticleId IdType="pubmed">18083105</ArticleId></ArticleIdList></Reference><Reference><Citation>Clarke LE, Liddelow SA, Chakraborty C, M&#xfc;nch AE, Heiman M, Barres BA.. Normal aging induces A1-like astrocyte reactivity. Proc Natl Acad Sci U S A. 2018;115(8):E1896&#x2013;E1905.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5828643</ArticleId><ArticleId IdType="pubmed">29437957</ArticleId></ArticleIdList></Reference><Reference><Citation>Perriot S, Mathias A, Perriard G, et al. . Human induced pluripotent stem cell-derived astrocytes are differentially activated by multiple sclerosis-associated cytokines. Stem Cell Reports. 2018;11(5):1199&#x2013;1210.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6234919</ArticleId><ArticleId IdType="pubmed">30409508</ArticleId></ArticleIdList></Reference><Reference><Citation>Clarke BE, Taha DM, Tyzack GE, Patani R.. Regionally encoded functional heterogeneity of astrocytes in health and disease: A perspective. Glia. 2021;69(1):20&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pubmed">32749770</ArticleId></ArticleIdList></Reference><Reference><Citation>Rostami J, Fotaki G, Sirois J, et al. . Astrocytes have the capacity to act as antigen-presenting cells in the Parkinson&#x2019;s disease brain. J Neuroinflamm. 2020;17(1):119.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7164247</ArticleId><ArticleId IdType="pubmed">32299492</ArticleId></ArticleIdList></Reference><Reference><Citation>Jarosinski KW, Massa PT.. Interferon regulatory factor-1 is required for interferon-gamma-induced MHC class I genes in astrocytes. J Neuroimmunol. 2002;122(1-2):74&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pubmed">11777545</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi SS, Lee HJ, Lim I, Satoh J-I, Kim SU.. Human astrocytes: Secretome profiles of cytokines and chemokines. PLoS ONE. 2014;9(4):e92325.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3972155</ArticleId><ArticleId IdType="pubmed">24691121</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>